Mehmet Demir, Ilyas Ozturk, Merve Aktar, Cihan Heybeli, Can Huzmeli, Orhan Ozdemir, Seda Safak Ozturk, Tulin Akagun, Neriman Sila Koc, Mehmet Tuncay, Ekrem Kara, Tuncay Sahutoglu
{"title":"Roxadustat Versus ESA Therapy for Sustained Hemoglobin Response in ESA-Hyporesponsive Hemodialysis Patients.","authors":"Mehmet Demir, Ilyas Ozturk, Merve Aktar, Cihan Heybeli, Can Huzmeli, Orhan Ozdemir, Seda Safak Ozturk, Tulin Akagun, Neriman Sila Koc, Mehmet Tuncay, Ekrem Kara, Tuncay Sahutoglu","doi":"10.1111/hdi.70116","DOIUrl":"https://doi.org/10.1111/hdi.70116","url":null,"abstract":"<p><strong>Background: </strong>In Erythropoiesis-Stimulating Agent (ESA)-hyporesponsive hemodialysis patients, hemoglobin (Hb) change from baseline may not fully capture durable treatment response. This secondary analysis evaluated sustained Hb ≥ 10 g/dL achievement and month-to-month Hb variability with roxadustat versus continued ESA therapy.</p><p><strong>Methods: </strong>This multicenter retrospective secondary analysis included adult maintenance hemodialysis patients with ESA-hyporesponsive anemia and complete monthly Hb data from Months 1-6. Sustained target achievement was defined as Hb ≥ 10 g/dL in at least 3 of 6 months. Hb variability was assessed using within-patient Hb SD, coefficient of variation, range, mean absolute monthly change, and maximum absolute change. Predictors were evaluated using logistic and linear regression.</p><p><strong>Results: </strong>Among 108 patients, 78 received roxadustat and 30 continued ESA therapy. Sustained Hb ≥ 10 g/dL achievement occurred in 52 patients. Roxadustat was associated with higher adjusted odds of sustained target achievement versus ESA therapy (adjusted OR: 4.44, 95% CI: 1.24-15.84; p = 0.022). Higher baseline Hb was also independently associated with sustained response (adjusted OR: 2.95 per 1 g/dL, 95% CI: 1.57-5.55; p < 0.001). By Month 6, Hb ≥ 10 g/dL was achieved by 50.0% of roxadustat-treated patients versus 33.3% of ESA-treated patients. Hb variability metrics were numerically lower with roxadustat but were not significantly different between groups.</p><p><strong>Conclusions: </strong>In ESA-hyporesponsive hemodialysis patients, roxadustat was associated with higher adjusted odds of sustained Hb ≥ 10 g/dL achievement but did not clearly reduce month-to-month Hb variability over 6 months. These retrospective findings support sustained target achievement as a clinically relevant response metric and warrant prospective validation.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148440357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Actor and Partner Effects of Dyadic Coping on Stress Among Hemodialysis Patients and Spouses.","authors":"Yajuan Xiao, Fazhan Chen, Yanbo Wang","doi":"10.1111/hdi.70098","DOIUrl":"https://doi.org/10.1111/hdi.70098","url":null,"abstract":"<p><strong>Aims and objectives: </strong>This study examined the interdependence among dyadic coping, self-efficacy, and stress in Chinese hemodialysis patients and their spouses using the actor-partner interdependence model.</p><p><strong>Background: </strong>End-stage kidney disease creates major psychological challenges for both patients and their spouses. The systemic transactional model views coping as a shared, dyadic process between partners. However, the specific actor and partner effects of dyadic coping on illness-related stress in hemodialysis couples remain understudied.</p><p><strong>Design: </strong>A cross-sectional correlational design was used.</p><p><strong>Methods: </strong>A convenience sample of 200 patient-spouse dyads, comprising 400 individuals, was included in the analytic dataset. Participants completed the dyadic coping inventory, hemodialysis stressor scale, and general self-efficacy scale. The actor-partner interdependence model was applied to analyze the dyadic data.</p><p><strong>Results: </strong>Paired tests showed significant asymmetry in coping, with spouses reporting higher dyadic coping than patients. Self-efficacy was positively correlated with dyadic coping for both patients and spouses. The actor-partner interdependence model analysis revealed significant actor effects: an individual's own dyadic coping predicted lower personal stress. A significant partner effect also emerged, indicating that a spouse's coping was associated with lower patient stress.</p><p><strong>Conclusion: </strong>These findings confirm the interdependent nature of coping within end-stage kidney disease dyads. Although spouses shoulder a greater share of the coping burden, their efforts effectively alleviate patient distress. Clinical interventions should move from patient-centered to couple-centered approaches that promote shared coping strategies, strengthen resilience, and reduce the risk of caregiver burnout.</p><p><strong>Relevance to clinical practice: </strong>The results support routine dyadic psychosocial assessment in hemodialysis care and the development of couple-based interventions. Such programs should build dyadic coping skills and self-efficacy in both partners while offering targeted support to prevent caregiver burnout.</p><p><strong>No patient or public contribution: </strong>This observational survey study did not include patient, caregiver, or public involvement in the design, conduct, analysis, or manuscript preparation beyond participants' completion of questionnaires.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148427754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Predictive Value of Platelet-to-Monocyte Ratio for Distal Arteriovenous Fistula Failure: A Retrospective Cohort Study.","authors":"Emine Aleyna Eroglu Polat, Guler Gulsen Ersoy","doi":"10.1111/hdi.70115","DOIUrl":"https://doi.org/10.1111/hdi.70115","url":null,"abstract":"<p><strong>Purpose: </strong>Arteriovenous (AV) fistula maturation remains a significant challenge in hemodialysis patients, frequently compromised by chronic inflammation and thrombotic events. This study aimed to investigate the predictive value of the Platelet-to-Monocyte Ratio and other systemic inflammatory markers in determining AV fistula maturation success.</p><p><strong>Materials and methods: </strong>This retrospective study included 186 patients who underwent autologous AV fistula creation between December 2022 and August 2025. Preoperative laboratory data, including complete blood count and C-reactive protein, were collected. Patients were divided into \"Success\" (n = 146) and \"Failure\" (n = 40) groups based on functional maturation within 4 weeks. Inflammatory indices (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-monocyte ratio, and C-reactive protein-to-albumin ratio) were calculated. Statistical analysis was performed using Python.</p><p><strong>Results: </strong>The maturation failure rate was 21.5%. Absolute monocyte counts were significantly lower in the failure group [0.55 vs. 0.69 (103/μL); p = 0.028]. The platelet-to-monocyte ratio was significantly higher in patients with maturation failure [343 vs. 284; p = 0.042]. In Receiver Operating Characteristic analysis, the platelet-to-monocyte ratio demonstrated the highest discriminative power among all indices (AUC: 0.61, cut-off: 236). However, the platelet-to-monocyte ratio was not identified as an independent risk factor in multivariate logistic regression (p = 0.244).</p><p><strong>Conclusion: </strong>A high preoperative platelet-to-monocyte ratio and low absolute monocyte count are associated with AV fistula maturation failure. While the platelet-to-monocyte ratio is not a strong independent predictor, it serves as an auxiliary biomarker reflecting the balance between thrombotic activity and vascular remodeling.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148407576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Effect of Education Using the Teach-Back Method on Symptoms of Depression in Hemodialysis Patients.","authors":"Elif Acar, Semiha Akin Eroglu, Busra Zehra Buyukkilic, Besey Oren, Hakki Cetinkaya","doi":"10.1111/hdi.70112","DOIUrl":"https://doi.org/10.1111/hdi.70112","url":null,"abstract":"<p><strong>Background: </strong>Recently, the Teach-Back Method has gained recognition in the literature as a promising, evidence-based strategy for patient education.</p><p><strong>Objective: </strong>This study aimed to assess the impact of individualized education delivered via the Teach-Back Method on depression levels among adult patients with kidney failure undergoing hemodialysis.</p><p><strong>Methods: </strong>A parallel-group trial with a pre-test and post-test design was conducted. The sample comprised 40 hemodialysis patients. Baseline (pre-test) data were collected from all participants. The intervention group received individualized education using the Teach-Back Method, delivered across three sessions. A post-test was administered 12 weeks after the initial assessment.</p><p><strong>Results: </strong>Pre-test depression scores were comparable between the intervention and control groups (mean = 13.35 and 13.55, respectively), reflecting mild depression. Following the intervention, the mean depression score in the intervention group decreased significantly to 6.20, indicating a reduction below the mild depression threshold. Conversely, the control group's post-test score increased to 16.40, remaining within the mild depression range.</p><p><strong>Conclusion: </strong>These findings suggest that Teach-Back education may reduce depression levels in hemodialysis patients. However, given the small sample size and relatively short follow-up period, larger studies with longer follow-up are needed to confirm these findings.</p><p><strong>Trial registration: </strong>NCT07069634.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148407512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
George Miller, Rukhaiya Fatima, Emma Albrecht, Madalyn Warden
{"title":"Determinants of 90-Day Infection Risk After Tunneled Dialysis Catheter Placement: Patient, Device, and Procedural Factors in a Large Real-World Dataset.","authors":"George Miller, Rukhaiya Fatima, Emma Albrecht, Madalyn Warden","doi":"10.1111/hdi.70113","DOIUrl":"https://doi.org/10.1111/hdi.70113","url":null,"abstract":"<p><strong>Introduction: </strong>Tunneled hemodialysis catheters remain widely used but carry substantial infection risk. While patient and procedural factors are established drivers of infection, the contribution of catheter design features is less characterized. We evaluated associations between device features and 90-day systemic infection-related events after tunneled hemodialysis catheter insertion.</p><p><strong>Methods: </strong>We conducted a retrospective observational study using deidentified electronic health record data from the Truveta database. We analyzed 47,750 tunneled hemodialysis catheter insertions among 37,074 patients between 2008 and 2024; 19,774 insertions among 16,517 patients met complete case criteria for primary adjusted modeling. We fit multivariable logistic regression models to estimate adjusted odds ratios (aORs), evaluating grouped device features and individual brands while adjusting for demographics, comorbidity burden, insertion site, catheter number, and calendar period.</p><p><strong>Findings: </strong>In complete case brand-agnostic models, higher adjusted odds were observed for femoral insertion (aOR 1.71), fourth or later catheter placement (aOR 1.41), and pre-curved configuration (aOR 1.29). Lower adjusted odds were observed for age ≥ 80 years (aOR 0.70), Black patients (aOR 0.86), Hispanic patients (aOR 0.66), COVID (aOR 0.72) and post-COVID periods (aOR 0.66), catheter length ≤ 24 cm (aOR 0.84), and French size < 14.5F (aOR 0.34). In full-dataset sensitivity analyses, unknown race, unknown sex, unknown insertion site, second and third catheter placement, higher comorbidity burden, and split-tip design were associated with higher odds. Brand-specific models showed heterogeneity relative to GlidePath beyond broad design categories.</p><p><strong>Discussion: </strong>Infection risk after tunneled hemodialysis catheter insertion was most consistently associated with insertion context, catheter history, calendar period, and demographics. Device-related findings were smaller and varied by model specification, with brand-level differences not fully explained by broad design categories. Future studies should incorporate granular device descriptors and facility-level context to clarify which design choices translate into meaningful differences in infection risk.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148398896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maaike Nielen, Maria K Svensson, Hans Furuland, Ursa Bonnevier, Ainhoa Indurain, Annica Sedin, Michael Eklund, Jenny Stenberg
{"title":"Bioimpedance and Symptom Guided Fluid Management in Hemodialysis: A Multicenter Pre-Post Implementation Study.","authors":"Maaike Nielen, Maria K Svensson, Hans Furuland, Ursa Bonnevier, Ainhoa Indurain, Annica Sedin, Michael Eklund, Jenny Stenberg","doi":"10.1111/hdi.70109","DOIUrl":"https://doi.org/10.1111/hdi.70109","url":null,"abstract":"<p><strong>Background: </strong>Optimizing volume status is central to hemodialysis care and may influence patient-reported outcome measures as recovery time. We evaluated the implementation of a structured decision aid (Recova) integrating symptom assessment with bioimpedance spectroscopy in routine hemodialysis practice.</p><p><strong>Methods: </strong>A prospective multicenter pre-post within-subjects study was conducted in 10 Swedish hemodialysis clinics. Clinics adopted the intervention on a staggered schedule based on local readiness. Participants were assessed at baseline and after 12 weeks. Outcomes included bioimpedance spectroscopy-derived overhydration and extracellular water, patient-reported recovery time (hours to resume usual activities), and a fluid-related symptom score. Paired measurements were compared.</p><p><strong>Results: </strong>Of 404 screened patients, 129 consented and 123 initiated the intervention. Recovery time data were available at both time points for 110 participants. Overhydration decreased from 2.6 ± 1.7 to 2.3 ± 2.0 L (p = 0.04) and extracellular water from 18.4 ± 4.0 to 18.0 ± 3.8 L (p = 0.01). Mean recovery time did not change significantly (6.7 ± 7.1 to 5.8 ± 6.2 h; p = 0.22) and median recovery time remained 4 h (IQR 1-10). Fluid-related symptom burden declined over the intervention period. No harms were reported; 13 participants did not complete the 12-week intervention.</p><p><strong>Conclusions: </strong>In this multicenter pre-post evaluation, implementation of Recova was associated with modest improvements in bioimpedance spectroscopy-derived volume metrics and fluid-related symptoms, while recovery time did not change significantly. Controlled studies are needed to determine effectiveness and to identify which patients may benefit.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148393044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lin Li, Zhongwang Zhang, Hongjie Wang, Mingdi Zhu, Kun Wang, Zheng Liu
{"title":"Utility of the SWAM (Separator With Aspirator for Mechanical Thrombectomy) Device in Managing Hemodialysis Access Thrombosis.","authors":"Lin Li, Zhongwang Zhang, Hongjie Wang, Mingdi Zhu, Kun Wang, Zheng Liu","doi":"10.1111/hdi.70111","DOIUrl":"https://doi.org/10.1111/hdi.70111","url":null,"abstract":"<p><strong>Background: </strong>Hemodialysis access thrombosis is the primary cause of access failure. Thrombus removal is an effective strategy to restore access function. Although both open surgical and endovascular procedures enable thrombus clearance, endovascular thrombus reduction therapy is widely adopted in clinical practice for this condition due to its minimally invasive and effective properties.</p><p><strong>Methods: </strong>We describe a novel separator-assisted catheter thrombectomy technique for the management of hemodialysis access thrombosis. In this procedure, a large-bore catheter is used for negative-pressure thrombus aspiration, with an embolus separator concurrently utilized to disrupt intraluminal thrombus and maintain catheter patency during aspiration.</p><p><strong>Results: </strong>This approach effectively enhances thrombus clearance efficiency and shortens procedural time. In our reported thrombectomy cases involving arteriovenous fistula (AV fistula), arteriovenous graft (AV graft), and central venous catheters, the SWAM (Separator With Aspirator for Mechanical Thrombectomy) technique achieved favorable therapeutic efficacy for acute thrombus and, to a certain extent, for chronic thrombus.</p><p><strong>Conclusion: </strong>This technique provides a novel therapeutic alternative for the management of hemodialysis access thrombosis.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148393066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Non-Cuffed Hemodialysis Catheter-Related Septic Thrombophlebitis of the Internal Jugular Vein Presenting With Recurrent Bacteremia and Septic Pulmonary Embolism.","authors":"Subrahmanian Sathiavageesan, Anand Chandrasekaran","doi":"10.1111/hdi.70067","DOIUrl":"10.1111/hdi.70067","url":null,"abstract":"<p><strong>Background: </strong>Central venous catheter is indispensable to urgent start and unplanned hemodialysis. Central venous catheters are prone to infectious complications like catheter related blood stream infection (CRBSI) and malfunction. Catheter-related septic thrombophlebitis is a serious, yet underrecognized complication of CRBSI. It often presents as persistent or recurrent bacteremia and septic pulmonary embolism.</p><p><strong>Case report: </strong>In this case report, we describe the case of an elderly woman on hemodialysis who presented with recurrent CRBSI and septic pulmonary embolism due to a right internal jugular vein non-cuffed central venous catheter-related septic thrombophlebitis. She required surgical thrombectomy since standard source control strategies like catheter removal and antibiotic therapy failed.</p><p><strong>Conclusion: </strong>We describe the surgical approach used in this patient and highlight the importance of prompt recognition and timely surgical intervention in catheter-related septic thrombophlebitis.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":"645-648"},"PeriodicalIF":1.2,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13350448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147438463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Donna L Oomens, Vincent Lee, Thomas D Daly, Brendan Winters, Steve Meikle, Jillian Clarke
{"title":"Comparison of Resistive Index and Volume Flow in Ultrasound of Arteriovenous Fistula for Dialysis Access.","authors":"Donna L Oomens, Vincent Lee, Thomas D Daly, Brendan Winters, Steve Meikle, Jillian Clarke","doi":"10.1111/hdi.70100","DOIUrl":"https://doi.org/10.1111/hdi.70100","url":null,"abstract":"<p><strong>Introduction: </strong>Despite extensive investigation, the optimal method of assessing arteriovenous fistula (AV fistula) function remains elusive. Ultrasound is an important tool in the assessment of AV fistula, with a wide range of protocols and flow criteria used across the literature. However, the operator dependency of ultrasound has the potential to impact the quality of the acquired measurements, particularly volume flow, and has been poorly reported. Therefore, incorporating other measurements such as resistive indices may increase the robustness of the ultrasound findings.</p><p><strong>Methods: </strong>This retrospective cohort study reviewed ultrasound and clinical data from two vascular ultrasound practices in Australia. All patients presenting with an upper limb AV fistula between January 2017 and October 2021 were included, stratified by indication for referral. The relationship between volume flow and resistive index was analyzed and predictive values were determined for two cutoff levels of resistive index (≤ 0.65 and ≤ 0.75) for a volume flow of ≥ 500 mL/min.</p><p><strong>Findings: </strong>Eight types of AV fistula were noted in the 1988 ultrasound examinations conducted by 9 sonographers. Analysis was based on the three major AV fistula types: radio-cephalic (1267), brachiocephalic (491) and brachio-basilic (193). There were significant differences in the median values for both resistive index and volume flow between AV fistula type and indication for study. At an resistive index of ≤ 0.65 or 0.75, the positive predictive value in the group referred for surveillance was 96.8% and 95.4% respectively for a volume flow ≥ 500 mL/min, while in the group referred for problematic AV fistula it was 92.5% and 83.8%.</p><p><strong>Conclusion: </strong>The addition of resistive index values can support confidence in the technically difficult volume flow measures, especially for sonographers with non-specialized vascular skills.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148364562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Effect of Virtual Museum Visit on Dialysis Symptoms and Anxiety in Hemodialysis Patients: A Randomized Controlled Trial.","authors":"Songül Mollaoğlu, Mukadder Mollaoğlu, Samet Korkmaz, Gülcan Bahçecioğlu Turan","doi":"10.1111/hdi.70107","DOIUrl":"https://doi.org/10.1111/hdi.70107","url":null,"abstract":"<p><strong>Objective: </strong>Complementary treatment methods support medical treatment in symptom control. The aim of this study was to investigate the effect of virtual museum visits on dialysis symptoms and anxiety in hemodialysis patients.</p><p><strong>Method: </strong>This randomized controlled trial included 60 participants (intervention group = 30, control group = 30). In the intervention group, a passive immersive virtual reality based virtual museum intervention was applied during hemodialysis sessions. Participants viewed pre-recorded museum environments through virtual reality glasses without interaction. The intervention was administered once weekly for five consecutive weeks (30 min per session). The control group received routine hemodialysis care only. Data were collected using a Patient Information Form, the Dialysis Symptom Index and the Beck Anxiety Inventory Outcomes were assessed at baseline and after completion of the intervention period.</p><p><strong>Results: </strong>The mean Dialysis Symptom Index and Beck Anxiety Inventory scores decreased more in the intervention group compared with the control group (p < 0.001). In addition, improvements in symptoms such as feeling uncomfortable, irritability, fatigue/decreased energy, bone/joint pain, muscle pain, and nausea were greater in the intervention group (p < 0.05). Within-group analyses showed significant reductions in both Dialysis Symptom Index and Beck Anxiety Inventory scores in the intervention group, while no significant changes were observed in the control group.</p><p><strong>Conclusion: </strong>Virtual museum visits using VR technology may be a supportive intervention for reducing dialysis-related symptoms and anxiety levels in hemodialysis patients. Further studies with larger samples and more robust designs are recommended to confirm these findings.</p>","PeriodicalId":94027,"journal":{"name":"Hemodialysis international. International Symposium on Home Hemodialysis","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148355132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}